Clinical-functional characterization of patients with spinal muscular atrophy in Central-Western Colombia
Biomedica, ISSN: 2590-7379, Vol: 42, Issue: Sp. 1, Page: 89-99
2022
- 2Citations
- 118Usage
- 44Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Introduction: Spinal muscular atrophy is a rare genetic neurodegenerative disorder affecting the motor neurons of the anterior horn of the spinal cord, which results in muscle atrophy and weakness. In Colombia, few studies have been published on the pathology and none with functional analysis. Objective: To characterize clinically and functionally some cases of spinal muscular atrophy patients from Central-Western Colombia. Materials and methods: We conducted a cross-sectional descriptive study between 2007 and 2020 with patients clinically and molecularly diagnosed with spinal muscular atrophy who attended a care center. For the functional assessment we used the Hammersmith and Chop-Intend scales and the data were systematized with the Epi-Info, version 7.0 software. Results: We analyzed 14 patients (42.8% men). The most prevalent spinal muscular atrophy was type II with 71.4%. We found phenotypic variability in terms of functionality in some patients with type II spinal muscular atrophy, 37.5% of whom reached gait. Survival was estimated at 28.6 years. Conclusions: The findings in the group of patients analyzed revealed that the scores of the revised and expanded Hammersmith scales correlated with the severity of SMA.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85133016829&origin=inward; http://dx.doi.org/10.7705/biomedica.6178; http://www.ncbi.nlm.nih.gov/pubmed/35866733; https://revistabiomedica.org/index.php/biomedica/article/view/6178; http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572022000500089&lng=en&tlng=en; http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S0120-41572022000500089&lng=en&tlng=en; http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572022000500089; http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S0120-41572022000500089; https://dx.doi.org/10.7705/biomedica.6178
Instituto Nacional de Salud (Colombia)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know